Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models
Open Access
- 1 January 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 7 (1) , 83-92
Abstract
The proposed ThT-based drug candidate series is validated as chemical tools for further in vivo development.Keywords
This publication has 66 references indexed in Scilit:
- The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseasesCoordination Chemistry Reviews, 2012
- Insight into Amyloid Structure Using Chemical ProbesChemical Biology & Drug Design, 2011
- Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP MiceLetters in Drug Design & Discovery, 2009
- Folding proteins in fatal waysNature, 2003
- Protein folding and misfoldingNature, 2003
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- The metallobiology of Alzheimer's diseaseTrends in Neurosciences, 2003
- Protein-misfolding diseases: Getting out of shapeNature, 2002
- Thioflavine T interaction with amyloid β-sheet structuresAmyloid, 1995
- Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.Journal of Histochemistry & Cytochemistry, 1989